ZIMMER BIOMET HOLDINGS INC (ZBH) Fundamental Analysis & Valuation
NYSE:ZBH • US98956P1021
Current stock price
90.42 USD
+1.8 (+2.03%)
At close:
90.42 USD
0 (0%)
After Hours:
This ZBH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZBH Profitability Analysis
1.1 Basic Checks
- ZBH had positive earnings in the past year.
- In the past year ZBH had a positive cash flow from operations.
- Each year in the past 5 years ZBH has been profitable.
- ZBH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ZBH (3.05%) is better than 76.06% of its industry peers.
- With a decent Return On Equity value of 5.55%, ZBH is doing good in the industry, outperforming 77.13% of the companies in the same industry.
- With a decent Return On Invested Capital value of 5.79%, ZBH is doing good in the industry, outperforming 77.66% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ZBH is below the industry average of 9.36%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROIC | 5.79% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
1.3 Margins
- Looking at the Profit Margin, with a value of 8.56%, ZBH belongs to the top of the industry, outperforming 81.38% of the companies in the same industry.
- ZBH's Profit Margin has improved in the last couple of years.
- The Operating Margin of ZBH (16.75%) is better than 86.17% of its industry peers.
- In the last couple of years the Operating Margin of ZBH has grown nicely.
- With a decent Gross Margin value of 69.71%, ZBH is doing good in the industry, outperforming 79.26% of the companies in the same industry.
- In the last couple of years the Gross Margin of ZBH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% |
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
2. ZBH Health Analysis
2.1 Basic Checks
- ZBH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- ZBH has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for ZBH has been reduced compared to 5 years ago.
- The debt/assets ratio for ZBH is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.39 indicates that ZBH is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of ZBH (2.39) is better than 66.49% of its industry peers.
- ZBH has a debt to FCF ratio of 6.72. This is a slightly negative value and a sign of low solvency as ZBH would need 6.72 years to pay back of all of its debts.
- The Debt to FCF ratio of ZBH (6.72) is better than 75.00% of its industry peers.
- ZBH has a Debt/Equity ratio of 0.55. This is a neutral value indicating ZBH is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.55, ZBH perfoms like the industry average, outperforming 41.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.57
WACC10.1%
2.3 Liquidity
- ZBH has a Current Ratio of 1.98. This is a normal value and indicates that ZBH is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.98, ZBH is not doing good in the industry: 63.83% of the companies in the same industry are doing better.
- ZBH has a Quick Ratio of 1.10. This is a normal value and indicates that ZBH is financially healthy and should not expect problems in meeting its short term obligations.
- ZBH's Quick ratio of 1.10 is on the low side compared to the rest of the industry. ZBH is outperformed by 73.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 |
3. ZBH Growth Analysis
3.1 Past
- ZBH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.50%.
- Measured over the past 5 years, ZBH shows a small growth in Earnings Per Share. The EPS has been growing by 7.66% on average per year.
- Looking at the last year, ZBH shows a small growth in Revenue. The Revenue has grown by 7.20% in the last year.
- Measured over the past years, ZBH shows a small growth in Revenue. The Revenue has been growing by 3.22% on average per year.
EPS 1Y (TTM)2.5%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%10.9%
3.2 Future
- Based on estimates for the next years, ZBH will show a small growth in Earnings Per Share. The EPS will grow by 6.55% on average per year.
- Based on estimates for the next years, ZBH will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
EPS Next Y3.4%
EPS Next 2Y5.28%
EPS Next 3Y5.55%
EPS Next 5Y6.55%
Revenue Next Year4.17%
Revenue Next 2Y3.94%
Revenue Next 3Y3.81%
Revenue Next 5Y4.39%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ZBH Valuation Analysis
4.1 Price/Earnings Ratio
- ZBH is valuated reasonably with a Price/Earnings ratio of 11.03.
- ZBH's Price/Earnings ratio is rather cheap when compared to the industry. ZBH is cheaper than 90.96% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.35. ZBH is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 10.66, the valuation of ZBH can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, ZBH is valued cheaply inside the industry as 92.02% of the companies are valued more expensively.
- ZBH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.61.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.03 | ||
| Fwd PE | 10.66 |
4.2 Price Multiples
- 91.49% of the companies in the same industry are more expensive than ZBH, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZBH indicates a rather cheap valuation: ZBH is cheaper than 93.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.8 | ||
| EV/EBITDA | 9.81 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZBH does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ZBH may justify a higher PE ratio.
PEG (NY)3.24
PEG (5Y)1.44
EPS Next 2Y5.28%
EPS Next 3Y5.55%
5. ZBH Dividend Analysis
5.1 Amount
- ZBH has a Yearly Dividend Yield of 1.04%.
- Compared to an average industry Dividend Yield of 0.24, ZBH pays a better dividend. On top of this ZBH pays more dividend than 92.02% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, ZBH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
- The dividend of ZBH has a limited annual growth rate of 0.12%.
- ZBH has been paying a dividend for at least 10 years, so it has a reliable track record.
- ZBH has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
- 27.01% of the earnings are spent on dividend by ZBH. This is a low number and sustainable payout ratio.
- The dividend of ZBH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP27.01%
EPS Next 2Y5.28%
EPS Next 3Y5.55%
ZBH Fundamentals: All Metrics, Ratios and Statistics
90.42
+1.8 (+2.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)05-04 2026-05-04/bmo
Inst Owners104.24%
Inst Owner Change5.05%
Ins Owners0.15%
Ins Owner Change10.37%
Market Cap17.69B
Revenue(TTM)8.23B
Net Income(TTM)704.60M
Analysts67.43
Price Target105.4 (16.57%)
Short Float %4.11%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.96
Dividend Growth(5Y)0.12%
DP27.01%
Div Incr Years0
Div Non Decr Years12
Ex-Date03-31 2026-03-31 (0.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.37%
Min EPS beat(2)0%
Max EPS beat(2)0.73%
EPS beat(4)4
Avg EPS beat(4)1.33%
Min EPS beat(4)0%
Max EPS beat(4)3.32%
EPS beat(8)6
Avg EPS beat(8)0.88%
EPS beat(12)9
Avg EPS beat(12)2.02%
EPS beat(16)13
Avg EPS beat(16)3.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)0.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.3%
Revenue beat(12)5
Avg Revenue beat(12)0.36%
Revenue beat(16)9
Avg Revenue beat(16)0.9%
PT rev (1m)-0.19%
PT rev (3m)0.96%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-3.34%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.03 | ||
| Fwd PE | 10.66 | ||
| P/S | 2.15 | ||
| P/FCF | 15.8 | ||
| P/OCF | 10.42 | ||
| P/B | 1.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.81 |
EPS(TTM)8.2
EY9.07%
EPS(NY)8.48
Fwd EY9.38%
FCF(TTM)5.72
FCFY6.33%
OCF(TTM)8.67
OCFY9.59%
SpS42.07
BVpS64.9
TBVpS-10.05
PEG (NY)3.24
PEG (5Y)1.44
Graham Number109.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROCE | 6.72% | ||
| ROIC | 5.79% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 22.61% | ||
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% | ||
| FCFM | 13.6% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
ROICexc(3y)6.74%
ROICexc(5y)6.13%
ROICexgc(3y)26.07%
ROICexgc(5y)24.68%
ROCE(3y)7.62%
ROCE(5y)6.94%
ROICexgc growth 3Y0.14%
ROICexgc growth 5Y10.7%
ROICexc growth 3Y1.16%
ROICexc growth 5Y14.26%
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
F-Score5
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 52.79% | ||
| Cap/Sales | 7.01% | ||
| Interest Coverage | 4.62 | ||
| Cash Conversion | 68.63% | ||
| Profit Quality | 158.91% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 2.39 |
F-Score5
WACC10.1%
ROIC/WACC0.57
Cap/Depr(3y)61.71%
Cap/Depr(5y)55.56%
Cap/Sales(3y)8.04%
Cap/Sales(5y)7.33%
Profit Quality(3y)115.26%
Profit Quality(5y)195.51%
High Growth Momentum
Growth
EPS 1Y (TTM)2.5%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%4.76%
EPS Next Y3.4%
EPS Next 2Y5.28%
EPS Next 3Y5.55%
EPS Next 5Y6.55%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%10.9%
Revenue Next Year4.17%
Revenue Next 2Y3.94%
Revenue Next 3Y3.81%
Revenue Next 5Y4.39%
EBIT growth 1Y-11.53%
EBIT growth 3Y4%
EBIT growth 5Y12.99%
EBIT Next Year29.58%
EBIT Next 3Y11.07%
EBIT Next 5Y8.8%
FCF growth 1Y24.09%
FCF growth 3Y10.12%
FCF growth 5Y7.09%
OCF growth 1Y13.19%
OCF growth 3Y9.72%
OCF growth 5Y7.1%
ZIMMER BIOMET HOLDINGS INC / ZBH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to ZBH.
Can you provide the valuation status for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a valuation rating of 7 / 10 to ZIMMER BIOMET HOLDINGS INC (ZBH). This can be considered as Undervalued.
How profitable is ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a profitability rating of 7 / 10.
What is the financial health of ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The financial health rating of ZIMMER BIOMET HOLDINGS INC (ZBH) is 4 / 10.
What is the expected EPS growth for ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The Earnings per Share (EPS) of ZIMMER BIOMET HOLDINGS INC (ZBH) is expected to grow by 3.4% in the next year.